Further insights into aspects of the EU illicit drugs market: summaries and key findings

Trautmann, F. and Kilmer, B. and Turnbull, Paul J. and May, Tiggey and Mcsweeney, Tim and Skrine, Oonagh (2013) Further insights into aspects of the EU illicit drugs market: summaries and key findings. Project Report. European Commission, Luxembourg.

Abstract

This publication presents key findings and summaries of selected reports from the study ‘Further insights into aspects of the EU illicit drugs market’ (Trautmann, Kilmer and Turnbull, forthcoming 2013), which provides an analysis of characteristics and operations of the EU’s illicit drugs market, as called for by the European Commission. This study is a follow-up of the earlier European Commission study, which presented an analysis of the developments of the global illicit drug markets, the drug problems and drug policy responses in the period 1998-2007 (Reuter and Trautmann 2009). The discussions of that study resulted in a number of further research questions. Some of the questions considered most important by the European Commission have been put together in a call for a further analysis of the EU illicit drugs market and responses to it, focusing on a number of aspects in the following four areas: A. An analysis of specific characteristics, mechanisms and factors that govern the EU illicit drugs market, including a conceptual framework for thinking about the structure of drug suppliers in the EU, an assessment whether there have been significant shifts in how drugs are supplied in the EU and an assessment of the extent to which drug suppliers are involved in different drugs and other criminal activities. B. A detailed analysis of the size and share of the EU illicit drug market, providing an estimate of the volume of the ‘EU market’ in illicit drugs (production and trafficking), providing an estimate of the profits generated by this market, analysing whether the EU drugs market is more supply or demand driven and exploring various aspects of drug use: user types, availability and consumption estimates. C. A detailed analysis of a number of potential policy impacts on the EU drug market(s) in recent years, assessing the impact of opioid substitution treatment (OST) on the European heroin market and the impact of policy changes on two EU drug markets. D. Scanning the future – trends in the market and policy responses, exploring expert views on future key trends of the illicit drug markets and policy responses in the EU.

Metadata

Statistics

DownloadsShow export options

Export as XMLJSONCSV

Activity Overview

6 month trend

239Downloads

6 month trend

821Hits

Additional statistics are available via IRStats2.

Archive Staff Only (login required)

Edit/View Item